New study aims to get more heart patients tested for hidden genetic risk
NCT ID NCT07508007
First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This study looks at whether special strategies can help doctors test more patients for Lp(a), a genetic risk factor for heart disease. Researchers will compare testing rates before and after these strategies are used in clinics. The goal is to see if simple changes can help follow medical guidelines and catch more at-risk patients.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- What this could lead to
- If successful, this could lead to more people being tested for Lp(a), helping doctors identify and manage heart disease risk earlier.
- What could go wrong
- This is an implementation study, not a treatment trial. It tests whether strategies boost testing rates, not whether testing improves health outcomes. Results may vary by clinic.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for IMPLEMENTING EAS/ESC GUIDELINE RECOMMENDATION ON LP(A) TESTING IN ROUTINE PRACTICE are added.
By submitting, you agree to our Terms of use
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Locations
-
Novartis Investigative Site
RECRUITINGNuremberg, 90443, Germany